Agios Pharmaceuticals Inc (STU:8AP)
€ 56 0 (0%) Market Cap: 3.20 Bil Enterprise Value: 2.30 Bil PE Ratio: 5.18 PB Ratio: 2.06 GF Score: 28/100

Agios Pharmaceuticals Inc to Host Investor Webcast Transcript

Dec 14, 2021 / 12:30PM GMT
Release Date Price: €27.76 (+6.12%)
Holly Manning
Agios Pharmaceuticals, Inc. - Senior Director of IR

All right. Well, it's 7:30, so we can go ahead and get started. A quick reminder for our attendees. So Dr. Kevin Kuo is with us, and we will be doing a short Q&A after his presentation because he has to drop off. And then we'll be doing a sort of additional Q&A at the end of the presentation. If you have a question, please submit it through the Q&A box. It should be at the right-hand side of your screen. You may have to click the 3 dots to see it. And if you have any issues, please shoot me an e-mail. And with that, I will turn it over to Jackie.

Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director

Great. Thank you, Holly. Good morning, everybody. Thank you for joining us early on this Tuesday morning, the last day of ASH 2021.

And Holly, if you could click to the next slide, please. These are forward-looking statements that I happily will not read to you this morning.

The next slide, please. This is our agenda for the day. We're very excited about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot